Keywords: novo, nordisk, changes, novoseven, formulation, uk, subsidiary

Novo Nordisk changes NovoSeven formulation

Article | 22 September 2008

Print This

The UK subsidiary of Denmark's Novo Nordisk says that NovoSeven, the only recombinant activated Factor VII product available for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in